Page last updated: 2024-08-21

durapatite and alendronate

durapatite has been researched along with alendronate in 70 studies

Research

Studies (70)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (4.29)	18.2507
2000's	14 (20.00)	29.6817
2010's	39 (55.71)	24.3611
2020's	14 (20.00)	2.80

Authors

Authors	Studies
Meraw, SJ; Reeve, CM; Wollan, PC	1
Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D	1
Meraw, SJ; Reeve, CM	1
Alferiev, IS; Amidon, GL; Breuer, E; Cohen, H; El Hanany-Rozen, N; Ezra, A; Gati, I; Golomb, G; Hoffman, A; Mönkkönen, J; Stepensky, D; Törmälehto, S; Weiss, G	1
Akisue, T; Bauer, TW; Brown, PR; Mochida, Y	1
Chandia, M; Costa, MC; Costa, MR; Fausto, R; Gano, L; Neves, M; Pereira, N; Rosado, M	1
Choi, SW; Kim, JH	1
Lee, HT; Liu, XM; Marky, LA; Reinhardt, RA; Wang, D	1
Bigi, A; Boanini, E; Gazzano, M; Giardino, R; Torricelli, P	1
Bonora, S; Casella, L; Falini, G; Foggia, MD; Iafisco, M; Nicolis, S; Palazzo, B; Roveri, N	1
Abu-Ali, S; Fotovati, A; Hayashi, K; Naito, M; Nakamura, Y	1
Goepferich, A; Mayr, H; Schuessele, A; Tessmar, J	1
Baas, J; Bechtold, JE; Elmengaard, B; Jakobsen, T; Kold, S; Søballe, K	1
Gong, Y; Ren, L; Shi, X; Wang, DA; Wang, Y	1
Ren, L; Shi, X; Varshney, RR; Wang, DA; Wang, Y; Zhang, F	1
Bigi, A; Boanini, E; Capuccini, C; Fini, M; Mihailescu, IN; Ristoscu, C; Sima, F; Torricelli, P	1
Canettieri, AC; Chin, CM; Colombo, CE; Faig-Leite, H	1
Henry, C; Jahnke, W	1
Ren, L; Shi, X; Wang, DA; Wang, Y; Yao, Y	1
Chen, J; Fang, Y; Gao, X; Hong, L; Ling, Y; Luo, Y; Pang, J; Wei, K	1
Hirano, M; Okawa, A; Shinomiya, K; Sotome, S; Sugata, Y; Yuasa, M	1
Goltz, D; Jauch, C; Schott, H; Schott, TC; Schwendener, RA	1
Bruni, G; Capra, P; Colonna, C; Conti, B; Dorati, R; Genta, I; Pavanetto, F	1
Roeder, RK; Ross, RD	1
Bigi, A; Boanini, E; Fini, M; Gazzano, M; Torricelli, P	2
Bhaduri, SB; Lawrence, JG; Touny, AH; Zhou, H	1
Cao, X; Niu, S; Zhang, Y; Zhu, J; Zhu, Q	1
Cao, X; Niu, S; Zhang, Y; Zhen, P; Zhu, J; Zhu, Q	1
Chen, X; Gao, C; Gou, Z; Huang, R; Li, Z; Sun, X; Xia, W; Yang, G; Yang, X; Zhang, G	1
Chang, BS; Koo, KH; Lee, CK; Lee, JH	1
Hu, X; Kang, ET; Neoh, KG; Shi, Z; Wang, W	1
Chen, L; Chen, X; Li, J; Tang, B; Wu, D; Wu, W; Yang, J	1
Bhaduri, SB; Zhou, H	1
Hong, KS; Jung, HS; Kim, SH; Park, JK; Seo, YK	1
Hayden, RS; Kaplan, DL; Vollrath, M	1
de Miguel, L; Iorga, BI; Noiray, M; Ponchel, G; Surpateanu, G	1
Dash, BC; Ling, J; Liu, G; Ruan, J; Wu, H; Xu, Y; Zhang, C	1
Cong, Y; Huang, G; Jiang, Q; Liu, J; Liu, M; Quan, C; Tong, G; Yin, Y; Zhang, C	1
Li, N; Shi, X; Song, J; Wang, Y; Zhu, G	1
Chen, L; Han, F; He, Z; Li, B; Ma, X; Zhong, Z	1
Bae, SK; Choi, SW; Jeong, KY; Jun, DR; Kang, RH; Kim, D; Koh, JM; Ryu, TK	1
Huang, Y; Li, X; Lv, M; Sun, J; Wang, N; Zhu, X	1
Aryal, S; Nguyen, TD; Pitchaimani, A	1
Chu, W; Cui, S; Huang, Y; Liao, Y; Yan, M; Yang, C; Zhang, X; Zhao, C	1
Chi, T; Fascetti, AJ; Ho, SP; Larsen, JA; Mellema, M; Mohr, C; Passlack, N; Queau, Y; Stoller, M; Westropp, JL	1
An, G; Shi, X; Song, J; Wang, L; Wang, Y; Zhu, G	1
Hu, Y; Lei, P; Liu, G; Liu, H; Niu, W; Ruan, J; Shrike Zhang, Y; Wu, H; Xie, J; Yang, J; Zhang, C; Zhang, L	1
Nikfar, Z; Shariatinia, Z	1
Bigi, A; Boanini, E; Fini, M; Forte, L; Rubini, K; Torricelli, P	1
Jin, Z; Song, X; Wang, Y; Zhang, J; Zhang, W; Zhang, Y	1
Grynpas, MD; Young, RN	1
Bandyopadhyay, A; Bose, S; Emshadi, K; Vu, AA	1
Cai, X; Chen, H; Cheng, Y; He, X; Huang, Q; Li, Y; Lin, K; Wang, Y; Xiao, J; Zhang, Q; Zou, Y	1
Abbadessa, A; Kucko, NW; Leeuwenburgh, SCG; Petre, DG; Polini, A; Vermonden, T	1
Bigi, A; Boanini, E; Fini, M; Giavaresi, G; Parrilli, A; Salamanna, F; Torricelli, P	1
Fu, Y; Li, Y; Song, J; Yang, S; Zhang, H	1
Chen, Z; Ding, C; Li, J; Wang, D; Wang, J; Wang, N; Wu, M; Xie, J; Xu, X	1
Kamble, S; Müllner, M; Pelras, T; Rohanizadeh, R; Varamini, P	1
Chang, H; Choi, TH; Jeon, B; Jeon, OH; Jung, HG; Kim, BJ; Kim, I; Lee, D; Lee, G; Wufuer, M; Yoon, DS	1
Budiatin, AS; Khotib, J; Mahyudin, F	1
Li, G; Liu, J; Niu, D; Wang, B; Wang, W; Wu, N; Xu, G; Yan, S; Yin, J; Yun, W; Zhang, K	1
Busquets-Cortés, C; Calvo, P; Costa-Bauzá, A; Grases, F; López-González, ÁA; Riutord, P; Sanchis, P	1
Chen, S; Jing, C; Li, B; Liang, H; Liu, C; Na, H; Tan, H; Zhang, C; Zhao, L	1
Ha, L; Kim, DP; Kim, JK; Kwon, YE; Lee, SG	1
Gupta, P; Gupta, S; Raman, N; Ramola, V; Shah, A; Singh, A	1
Lee, CS; Lee, KK; Lee, SC; Raja, N; Yun, HS	1
Bartoš, M; Buzgo, M; Filová, E; Hedvičáková, V; Hovořáková, M; Klein, P; Luňáčková, J; Paurová, I; Rampichová, M; Rysová, M; Šebová, E; Steklíková, K; Vištejnová, L; Žižková, R	1
Aryani, T; Budiatin, AS; Firdaus, AI; Gani, MA; Khotib, J; Maulidina, A; Nisak, K; Syukriya, AJ	1
Cheng, Z; Dai, Z; Jia, W; Jiang, X; Jiao, K; Liu, G; Liu, L; Liu, Y; Luo, Y; Sun, M; Wang, H; Wang, S; Yang, T; Yang, Y	1

Reviews

1 review(s) available for durapatite and alendronate

Article	Year
Targeting therapeutics to bone by conjugation with bisphosphonates. Current opinion in pharmacology, 2018, Volume: 40 Topics: Alendronate; Animals; Bone and Bones; Bone Diseases; Delayed-Action Preparations; Diphosphonates; Drug Carriers; Drug Compounding; Durapatite; Humans; Prodrugs; Prostaglandins; Receptors, Prostaglandin E, EP4 Subtype	2018

Other Studies

69 other study(ies) available for durapatite and alendronate

Article	Year
Use of alendronate in peri-implant defect regeneration. Journal of periodontology, 1999, Volume: 70, Issue:2 Topics: Alendronate; Animals; Bone Regeneration; Coated Materials, Biocompatible; Collagen; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis Design; Dogs; Durapatite; Fluorescent Dyes; Guided Tissue Regeneration, Periodontal; Image Processing, Computer-Assisted; Mandible; Membranes, Artificial; Osseointegration; Osteogenesis; Surface Properties; Titanium	1999
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate. Pharmaceutical research, 1999, Volume: 16, Issue:9 Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neoplasms; Calcium; Capsules; Carcinoma 256, Walker; Cell Line; Diphosphonates; Diuretics, Osmotic; Durapatite; Injections, Intravenous; Intestinal Absorption; Macrophages; Male; Mannitol; Osteogenesis; Pamidronate; Rats; Rats, Inbred Strains; Tight Junctions; Tissue Distribution	1999
Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. Journal of periodontology, 1999, Volume: 70, Issue:10 Topics: Alendronate; Animals; Bone and Bones; Bone Regeneration; Coated Materials, Biocompatible; Dental Alloys; Dental Implantation, Endosseous; Dental Implants; Dogs; Durapatite; Male; Multivariate Analysis; Time Factors; Titanium	1999
A peptide prodrug approach for improving bisphosphonate oral absorption. Journal of medicinal chemistry, 2000, Oct-05, Volume: 43, Issue:20 Topics: Administration, Oral; Alendronate; Animals; Biological Availability; Caco-2 Cells; Carrier Proteins; Chemical Precipitation; Dipeptides; Diphosphonates; Durapatite; Humans; Injections, Intravenous; Intestinal Absorption; Pamidronate; Peptide Transporter 1; Prodrugs; Rats; Symporters; Tissue Distribution	2000
Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants: a preliminary study. The Journal of bone and joint surgery. American volume, 2002, Volume: 84, Issue:2 Topics: Alendronate; Animals; Arthroplasty, Replacement, Hip; Bone Remodeling; Bone Resorption; Dogs; Durapatite; Follow-Up Studies; Osteoclasts; Postoperative Care	2002
Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies. Nuclear medicine and biology, 2002, Volume: 29, Issue:3 Topics: Alendronate; Animals; Bone and Bones; Diphosphonates; Durapatite; Energy Transfer; Female; Mice; Models, Molecular; Molecular Conformation; Pamidronate; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Samarium; Tissue Distribution	2002
Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. Journal of controlled release : official journal of the Controlled Release Society, 2007, Sep-11, Volume: 122, Issue:1 Topics: Adsorption; Alendronate; Bone and Bones; Drug Carriers; Drug Delivery Systems; Drug Design; Durapatite; Lactic Acid; Magnetic Resonance Spectroscopy; Molecular Weight; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrophotometry, Ultraviolet	2007
Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity. Journal of controlled release : official journal of the Controlled Release Society, 2007, Sep-11, Volume: 122, Issue:1 Topics: Alendronate; beta-Cyclodextrins; Calorimetry; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Durapatite; Kinetics; Magnetic Resonance Spectroscopy; Mouth; Solubility	2007
Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomaterials, 2008, Volume: 29, Issue:7 Topics: Alendronate; Cell Differentiation; Cell Line; Cell Proliferation; Durapatite; Humans; Matrix Metalloproteinases; Microscopy, Electron, Scanning; Models, Molecular; Molecular Conformation; Nanocomposites; Osteoblasts; X-Ray Diffraction	2008
Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate. Langmuir : the ACS journal of surfaces and colloids, 2008, May-06, Volume: 24, Issue:9 Topics: Adsorption; Alendronate; Animals; Biomimetic Materials; Durapatite; Horses; Kinetics; Microscopy, Electron, Transmission; Models, Biological; Models, Molecular; Myoglobin; Nanoparticles; Protein Conformation; Spectrophotometry	2008
Effect of preoperative combined treatment with alendronate and calcitriol on fixation of hydroxyapatite-coated implants in ovariectomized rats. The Journal of bone and joint surgery. American volume, 2008, Volume: 90, Issue:4 Topics: Absorptiometry, Photon; Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Calcitriol; Coated Materials, Biocompatible; Disease Models, Animal; Drug Combinations; Durapatite; Female; Femur; Osteoporosis; Ovariectomy; Preoperative Care; Prostheses and Implants; Rats; Rats, Wistar	2008
Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. Journal of biomedical materials research. Part A, 2009, Sep-15, Volume: 90, Issue:4 Topics: Alendronate; Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Ceramics; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Immobilized Proteins; Mice; Muramidase; Osteoblasts; Pamidronate	2009
Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2009, Volume: 27, Issue:2 Topics: Alendronate; Alloys; Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Dogs; Durapatite; Female; Materials Testing; Models, Animal; Osseointegration; Prostheses and Implants; Shear Strength; Tibia; Titanium	2009
Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharmaceutical research, 2009, Volume: 26, Issue:2 Topics: Alendronate; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Regeneration; Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Durapatite; Emulsions; Humans; Kinetics; Lactic Acid; Macrophages; Microspheres; Osteoblasts; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties	2009
In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials, 2009, Volume: 30, Issue:23-24 Topics: Alendronate; Animals; Bone Density Conservation Agents; Cells, Cultured; Drug Carriers; Durapatite; Lactic Acid; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Phosphatidic Acids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Silicon Dioxide; Synovial Membrane	2009
Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation. Biomaterials, 2009, Volume: 30, Issue:31 Topics: Alendronate; Biocompatible Materials; Cell Adhesion; Cell Proliferation; Cells, Cultured; Durapatite; Humans; Microscopy, Electron, Scanning; Nanoparticles; Osteoblasts; Titanium; X-Ray Diffraction	2009
Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite. International journal of experimental pathology, 2009, Volume: 90, Issue:5 Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Regeneration; Drug Combinations; Drug Evaluation, Preclinical; Durapatite; Female; Femur; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Wound Healing	2009
An in vitro assay to measure targeted drug delivery to bone mineral. ChemMedChem, 2010, May-03, Volume: 5, Issue:5 Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid	2010
In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold. Journal of biomaterials science. Polymer edition, 2010, Volume: 21, Issue:8-9 Topics: Alendronate; Animals; Cell Differentiation; Delayed-Action Preparations; Dexamethasone; Drug Carriers; Durapatite; Glycolates; Lactic Acid; Mechanical Phenomena; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Spectroscopy, Fourier Transform Infrared; Synovial Membrane; Tissue Scaffolds	2010
Synthesis, characterization and osteoconductivity properties of bone fillers based on alendronate-loaded poly(ε-caprolactone)/hydroxyapatite microspheres. Journal of materials science. Materials in medicine, 2011, Volume: 22, Issue:3 Topics: Alendronate; Alkaline Phosphatase; Bone and Bones; Bone Substitutes; Cell Proliferation; Cell Survival; Durapatite; Humans; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Particle Size; Polyesters; Spectroscopy, Fourier Transform Infrared	2011
Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits. The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:4 Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Case-Control Studies; Collagen; Durapatite; Male; Models, Animal; Osteoclasts; Osteogenesis; Osteoporosis; Rabbits; Random Allocation	2011
N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate). Bioorganic & medicinal chemistry, 2011, Jun-01, Volume: 19, Issue:11 Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Bone and Bones; Bone Density Conservation Agents; Cell Line, Tumor; Cytidine; Diphosphonates; Drug Screening Assays, Antitumor; Durapatite; Fluorouracil; Humans; Macrophages; Mice; Pamidronate; Uridine; Zidovudine	2011
A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials. Journal of microencapsulation, 2011, Volume: 28, Issue:5 Topics: Alendronate; Biocompatible Materials; Bone Density Conservation Agents; Drug Carriers; Durapatite; Humans; Materials Testing	2011
Binding affinity of surface functionalized gold nanoparticles to hydroxyapatite. Journal of biomedical materials research. Part A, 2011, Volume: 99, Issue:1 Topics: Alendronate; Aminoethylphosphonic Acid; Animals; Calcium; Cattle; Durapatite; Glutamic Acid; Gold; Metal Nanoparticles; Serum	2011
The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro. Biomaterials, 2012, Volume: 33, Issue:2 Topics: Alendronate; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphonates; Durapatite; Humans; Imidazoles; Microscopy, Electron, Scanning; Nanocomposites; Nanoparticles; Osteoblasts; Osteoclasts; X-Ray Diffraction; Zoledronic Acid	2012
Biomimetic coating of bisphosphonate incorporated CDHA on Ti6Al4V. Journal of materials science. Materials in medicine, 2012, Volume: 23, Issue:2 Topics: Alendronate; Alloys; Calcium; Cell Proliferation; Coated Materials, Biocompatible; Diphosphonates; Drug Delivery Systems; Durapatite; Humans; Materials Testing; Microscopy, Electron, Scanning; Osteoblasts; Osteoporosis; Sodium; Temperature; Time Factors; Titanium; X-Ray Diffraction	2012
The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover. The Journal of surgical research, 2013, Volume: 179, Issue:1 Topics: Alendronate; Animals; Bone Density; Cytokines; Durapatite; Male; Models, Animal; Orthopedics; Osteolysis; Prostheses and Implants; Rabbits; Synovial Membrane; Tibia	2013
Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover. BMC musculoskeletal disorders, 2012, Jun-11, Volume: 13 Topics: Alendronate; Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Disease Models, Animal; Durapatite; Male; Materials Testing; Osseointegration; Osteogenesis; Prostheses and Implants; Prosthesis Design; Prosthesis Implantation; Rabbits; Tibia	2012
Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals. Journal of inorganic biochemistry, 2012, Volume: 113 Topics: Alendronate; Biomimetic Materials; Bone and Bones; Bone Density Conservation Agents; Calcium Phosphates; Cetrimonium; Cetrimonium Compounds; Durapatite; Micelles; Models, Biological; Nanoparticles; Phase Transition; Surface-Active Agents; Time Factors	2012
The effect of alendronate doped calcium phosphates on bone cells activity. Bone, 2012, Volume: 51, Issue:5 Topics: Alendronate; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Coculture Techniques; Diphosphonates; Durapatite; Humans; Microscopy, Electron, Scanning; Osteoblasts; Osteoclasts; X-Ray Diffraction	2012
Effects of alendronate on lumbar posterolateral fusion using hydroxyapatite in rabbits. Artificial organs, 2012, Volume: 36, Issue:12 Topics: Alendronate; Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Density Conservation Agents; Durapatite; Lumbar Vertebrae; Rabbits; Spinal Fusion; Tomography, X-Ray Computed	2012
An in vitro assessment of fibroblast and osteoblast response to alendronate-modified titanium and the potential for decreasing fibrous encapsulation. Tissue engineering. Part A, 2013, Volume: 19, Issue:17-18 Topics: 3T3 Cells; Alendronate; Alkaline Phosphatase; Animals; Apoptosis; Bone Density Conservation Agents; Cell Proliferation; Durapatite; Fibroblasts; Mice; Osteoblasts; Titanium	2013
Hydroxyapatite-anchored dendrimer for in situ remineralization of human tooth enamel. Biomaterials, 2013, Volume: 34, Issue:21 Topics: Acid Etching, Dental; Acoustics; Adsorption; Alendronate; Animals; Cell Death; Dendrimers; Dental Enamel; Durapatite; Hardness; Hep G2 Cells; Humans; Male; Rats; Rats, Sprague-Dawley; Spectrophotometry, Infrared; Tooth; Tooth Remineralization; X-Ray Diffraction	2013
Deposition of PLA/CDHA composite coating via electrospraying. Journal of biomaterials science. Polymer edition, 2013, Volume: 24, Issue:7 Topics: Alendronate; Animals; Biocompatible Materials; Calcium; Cell Adhesion; Cell Differentiation; Cell Line; Durapatite; Lactic Acid; Mice; Osteoblasts; Polyesters; Polymers; Surface Properties	2013
Immobilization of BMP-2 on a nano-hydroxyapatite-coated titanium surface using a chitosan calcium chelating agent. The International journal of artificial organs, 2013, Volume: 36, Issue:7 Topics: Alendronate; Bone Morphogenetic Protein 2; Calcium; Cell Adhesion; Cell Proliferation; Cell Shape; Chelating Agents; Chitosan; Coated Materials, Biocompatible; Dental Implants; Drug Carriers; Durapatite; Gene Expression Regulation; Humans; Jurkat Cells; Mesenchymal Stem Cells; Nanoparticles; Nanotechnology; Osteogenesis; Prosthesis Design; Surface Properties; Tissue Scaffolds; Titanium	2013
Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films. Acta biomaterialia, 2014, Volume: 10, Issue:1 Topics: Alendronate; Animals; Bombyx; Calcium; Clodronic Acid; Coculture Techniques; Diphosphonates; Durapatite; Humans; Osteoblasts; Osteoclasts; Silk; Surface Properties	2014
Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting. International journal of pharmaceutics, 2014, Jan-02, Volume: 460, Issue:1-2 Topics: Alendronate; Bone and Bones; Bone Density Conservation Agents; Drug Delivery Systems; Durapatite; Models, Molecular; Nanoparticles; Polyethylene Glycols; Polyglutamic Acid	2014
Emulsion cross-linked chitosan/nanohydroxyapatite microspheres for controlled release of alendronate. Journal of materials science. Materials in medicine, 2014, Volume: 25, Issue:12 Topics: Alendronate; Animals; Bone Density Conservation Agents; Capsules; Cell Differentiation; Cells, Cultured; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Durapatite; Emulsions; Nanoparticles; Osteoblasts; Osteogenesis; Rabbits; Stem Cells	2014
Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. Journal of biomaterials science. Polymer edition, 2015, Volume: 26, Issue:11 Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone and Bones; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Liberation; Durapatite; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Vancomycin	2015
Alendronate conjugated nanoparticles for calcification targeting. Colloids and surfaces. B, Biointerfaces, 2016, Jun-01, Volume: 142 Topics: Alendronate; Animals; Bone Density Conservation Agents; Calcification, Physiologic; Cell Proliferation; Cell Survival; Dopamine; Drug Carriers; Durapatite; Humans; Hydrogels; Lactic Acid; Mice; Nanoparticles; NIH 3T3 Cells; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerization	2016
Preparation of collagen/hydroxyapatite/alendronate hybrid hydrogels as potential scaffolds for bone regeneration. Colloids and surfaces. B, Biointerfaces, 2016, Jul-01, Volume: 143 Topics: Alendronate; Animals; Biomimetic Materials; Bone and Bones; Bone Density Conservation Agents; Cell Adhesion; Cell Line; Cell Proliferation; Cell Survival; Collagen; Collagenases; Cross-Linking Reagents; Durapatite; Hydrogels; Hydrolysis; Iridoids; Mice; Osteoblasts; Phase Transition; Tissue Engineering; Tissue Scaffolds	2016
Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment. Journal of controlled release : official journal of the Controlled Release Society, 2016, 06-28, Volume: 232 Topics: Alendronate; Alkaline Phosphatase; Animals; Bone and Bones; Bone Density Conservation Agents; Cell Line; Drug Carriers; Durapatite; Female; Hep G2 Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Nanodiamonds; Osteoporosis	2016
Inhibition of fibrous dysplasia via blocking Gsα with suramin sodium loaded with an alendronate-conjugated polymeric drug delivery system. Biomaterials science, 2016, Jul-21, Volume: 4, Issue:7 Topics: Alendronate; Animals; Bone Marrow Cells; Cell Culture Techniques; Cell Line; Drug Carriers; Durapatite; Epoxy Compounds; Ethanolamines; Fibroblasts; Fibrous Dysplasia of Bone; GTP-Binding Protein alpha Subunits, Gs; Humans; Mesenchymal Stem Cells; Methacrylates; Mice; Nanoparticles; Polyamines; Polyethylene Glycols; Suramin	2016
Engineered Nanomedicine with Alendronic Acid Corona Improves Targeting to Osteosarcoma. Scientific reports, 2016, 11-08, Volume: 6 Topics: Alendronate; Biocompatible Materials; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cell Separation; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Durapatite; Flow Cytometry; Humans; Inhibitory Concentration 50; Ligands; Lipids; Magnetic Resonance Spectroscopy; Nanomedicine; Nanoparticles; Osteosarcoma; Polyglycolic Acid; Protein Engineering; Spectroscopy, Fourier Transform Infrared	2016
Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis. International journal of pharmaceutics, 2017, Jan-10, Volume: 516, Issue:1-2 Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Calcium Phosphates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Durapatite; Female; Humans; Methotrexate; Mice; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution	2017
Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine. PloS one, 2016, Volume: 11, Issue:12 Topics: Alendronate; Animals; Calcifying Nanoparticles; Cats; Citric Acid; Durapatite; Female; Fluorescent Dyes; Male; Microscopy, Electron, Transmission; Osteopontin; Particle Size; Urolithiasis	2016
Assembling of electrospun meshes into three-dimensional porous scaffolds for bone repair. Biofabrication, 2017, Feb-14, Volume: 9, Issue:1 Topics: Alendronate; Bone Regeneration; Cell Adhesion; Cell Culture Techniques; Cell Differentiation; Cell Line; Cell Proliferation; Durapatite; Humans; Microscopy, Electron, Scanning; Nanofibers; Osteoblasts; Osteogenesis; Photoelectron Spectroscopy; Polyesters; Porosity; Surface Properties; Tissue Engineering; Tissue Scaffolds	2017
Reconstruction of Large-scale Defects with a Novel Hybrid Scaffold Made from Poly(L-lactic acid)/Nanohydroxyapatite/Alendronate-loaded Chitosan Microsphere: in vitro and in vivo Studies. Scientific reports, 2017, 03-23, Volume: 7, Issue:1 Topics: Alendronate; Animals; Bone Regeneration; Bone Substitutes; Cells, Cultured; Chitosan; Drug Delivery Systems; Durapatite; In Vitro Techniques; Lactic Acid; Microspheres; Osteogenesis; Rabbits; Tissue Engineering; Tissue Scaffolds	2017
Phosphate functionalized (4,4)-armchair CNTs as novel drug delivery systems for alendronate and etidronate anti-osteoporosis drugs. Journal of molecular graphics & modelling, 2017, Volume: 76 Topics: Alendronate; Drug Carriers; Drug Delivery Systems; Durapatite; Etidronic Acid; Osteoporosis; Phosphates	2017
Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage. Journal of biomedical materials research. Part A, 2017, Volume: 105, Issue:12 Topics: Alendronate; Antioxidants; Biocompatible Materials; Bone Density Conservation Agents; Cell Line; Coculture Techniques; Drug Delivery Systems; Durapatite; Humans; Osteoblasts; Osteoclasts; Oxidative Stress; Quercetin; X-Ray Diffraction	2017
Synthesis and evaluation of a novel Chemical biology & drug design, 2018, Volume: 91, Issue:2 Topics: Alendronate; Animals; Bone and Bones; Bone Density Conservation Agents; Drug Stability; Durapatite; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Protein Binding; Rabbits; Radiopharmaceuticals; Serum Albumin; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	2018
Effects of polycaprolactone on alendronate drug release from Mg-doped hydroxyapatite coating on titanium. Materials science & engineering. C, Materials for biological applications, 2018, Jul-01, Volume: 88 Topics: Alendronate; Coated Materials, Biocompatible; Delayed-Action Preparations; Durapatite; Magnesium; Polyesters; Titanium	2018
Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis. Biomaterials, 2018, Volume: 183 Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cells, Cultured; Combined Modality Therapy; Durapatite; Heterografts; Hyperthermia, Induced; Indoles; Infrared Rays; Irinotecan; Melanins; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteolysis; Phototherapy; Polymers; Tissue Distribution	2018
Surface functionalization of polylactic acid fibers with alendronate groups does not improve the mechanical properties of fiber-reinforced calcium phosphate cements. Journal of the mechanical behavior of biomedical materials, 2019, Volume: 90 Topics: Aldehydes; Alendronate; Biocompatible Materials; Bone Cements; Calcium Phosphates; Durapatite; Materials Testing; Mechanical Phenomena; Polyesters; Surface Properties	2019
Antiresorptive properties of strontium substituted and alendronate functionalized hydroxyapatite nanocrystals in an ovariectomized rat spinal arthrodesis model. Materials science & engineering. C, Materials for biological applications, 2019, Feb-01, Volume: 95 Topics: Alendronate; Animals; Arthrodesis; Biocompatible Materials; Durapatite; Female; Lumbar Vertebrae; Ovariectomy; Rats; Strontium	2019
FITC-Labeled Alendronate as an In Vivo Bone pH Sensor. BioMed research international, 2020, Volume: 2020 Topics: Alendronate; Animals; Bone and Bones; Durapatite; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Male; Mice, Nude; Monitoring, Physiologic; Optical Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution	2020
Programmed antibacterial and mineralization therapy for dental caries based on zinc-substituted hydroxyapatite/ alendronate-grafted polyacrylic acid hybrid material. Colloids and surfaces. B, Biointerfaces, 2020, Volume: 194 Topics: Acrylic Resins; Alendronate; Anti-Bacterial Agents; Cariostatic Agents; Dental Caries; Durapatite; Humans; Tooth Remineralization; Zinc	2020
Bisphosphonate-functionalized micelles for targeted delivery of curcumin to metastatic bone cancer. Pharmaceutical development and technology, 2020, Volume: 25, Issue:9 Topics: Alendronate; Antineoplastic Agents; Bone Neoplasms; Curcumin; Diphosphonates; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Micelles; Nanoparticles; Particle Size; Poloxamer; Polymers; Tumor Microenvironment	2020
Sequential dual-drug delivery of BMP-2 and alendronate from hydroxyapatite-collagen scaffolds for enhanced bone regeneration. Scientific reports, 2021, 01-12, Volume: 11, Issue:1 Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Differentiation; Durapatite; Male; Rats; Rats, Sprague-Dawley; Tissue Engineering; Tissue Scaffolds	2021
Fabrication and characterization of bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked by glutaraldehyde for bone regeneration. Journal of basic and clinical physiology and pharmacology, 2021, Jun-25, Volume: 32, Issue:4 Topics: Alendronate; Animals; Bone Regeneration; Cattle; Durapatite; Gelatin; Glutaral; Tissue Scaffolds	2021
Mussel-Inspired Bisphosphonated Injectable Nanocomposite Hydrogels with Adhesive, Self-Healing, and Osteogenic Properties for Bone Regeneration. ACS applied materials & interfaces, 2021, Jul-21, Volume: 13, Issue:28 Topics: Adhesives; Alendronate; Animals; Biocompatible Materials; Biomimetic Materials; Bone and Bones; Bone Regeneration; Cell Line; Cell Physiological Phenomena; Dextrans; Durapatite; Female; Hydrogels; Male; Mice; Nanocomposites; Osteogenesis; Polyglutamic Acid; Rats, Sprague-Dawley; Swine; Tissue Engineering; Tissue Scaffolds	2021
Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases. Nutrients, 2021, Aug-20, Volume: 13, Issue:8 Topics: Absorptiometry, Photon; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases; Cross-Sectional Studies; Diet; Durapatite; Etidronic Acid; Female; Humans; Middle Aged; Phytic Acid; Postmenopause; Prospective Studies; Solubility; Spain	2021
Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment. ACS applied bio materials, 2021, 06-21, Volume: 4, Issue:6 Topics: Alendronate; Alginates; Animals; beta-Cyclodextrins; Bone and Bones; Bone Density Conservation Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Durapatite; Erythrocytes; Goats; Hemolysis; Mice; Nanoparticles; Osteoporosis; Polylactic Acid-Polyglycolic Acid Copolymer	2021
Rapid Flow Synthesis of a Biomimetic Carbonate Apatite as an Effective Drug Carrier. ACS applied materials & interfaces, 2022, Jul-06, Volume: 14, Issue:26 Topics: Alendronate; Apatites; Biomimetic Materials; Biomimetics; Drug Carriers; Durapatite	2022
Comparison between Different Combinations of Alendronate, Platelet-rich Fibrin, Hydroxyapatite in Bone Regeneration in Endodontic Surgeries Using Cone-beam Computed Tomography. The journal of contemporary dental practice, 2022, Mar-01, Volume: 23, Issue:3 Topics: Alendronate; Bone Regeneration; Cone-Beam Computed Tomography; Durapatite; Humans; Platelet-Rich Fibrin	2022
Multifunctional bone substitute using carbon dot and 3D printed calcium-deficient hydroxyapatite scaffolds for osteoclast inhibition and fluorescence imaging. Acta biomaterialia, 2023, 03-15, Volume: 159 Topics: Alendronate; Animals; Bone Substitutes; Calcium; Carbon; Durapatite; Mice; Mice, Nude; Optical Imaging; Printing, Three-Dimensional	2023
The Gradual Release of Alendronate for the Treatment of Critical Bone Defects in Osteoporotic and Control Rats. International journal of nanomedicine, 2023, Volume: 18 Topics: Alendronate; Animals; Bone Density Conservation Agents; Durapatite; Emulsions; Osteoblasts; Osteoclasts; Osteogenesis; Rats	2023
The administration of bovine hydroxyapatite-alendronate implant accelerates bone defect healing in an osteoporotic rat. Technology and health care : official journal of the European Society for Engineering and Medicine, 2023, Volume: 31, Issue:5 Topics: Alendronate; Animals; Cattle; Durapatite; Female; Osteoporosis; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A	2023
An osteoporosis bone defect regeneration strategy via three-dimension short fibers loaded with alendronate modified hydroxyapatite. Colloids and surfaces. B, Biointerfaces, 2024, Volume: 233 Topics: Alendronate; Bone Regeneration; Bone Resorption; Durapatite; Humans; Osteogenesis; Osteoporosis; Polyesters; Tissue Engineering; Tissue Scaffolds	2024